Literature DB >> 26456250

Dissolution performance of binary amorphous drug combinations--Impact of a second drug on the maximum achievable supersaturation.

Niraj S Trasi1, Lynne S Taylor2.   

Abstract

An increased number of amorphous formulations of poorly water soluble drugs are being introduced into the market due to their higher transient solubility and thus faster absorption and higher bioavailability. While most amorphous drug products contain a single drug substance, there is a growing trend towards co-formulating compounds in the same dosage form to improve patient compliance. The purpose of the present work was to evaluate the dissolution behavior and maximum achievable solution concentrations of amorphous solid dispersions of co-formulated ritonavir and lopinavir, and to compare the results with individual amorphous solid dispersion formulations. Dispersions of ritonavir and lopinavir were prepared in polyvinylpyrrolidone (PVP) or hydroxypropylmethylcellulose acetate succinate (HPMCAS) at a 20% (w/w) total drug loading, both alone and in combination, at three different lopinavir:ritonavir weight ratios. Amorphous films containing both drugs, but no polymer, were also prepared. The dissolution behavior of the dispersions and the amorphous films in non-sink conditions was evaluated, using ultracentrifugation to separate any colloidal material from molecularly dissolved drug. Nanoparticle tracking analysis was used to characterize colloidal material formed during the dissolution process. Results from the dissolution study revealed that, although supersaturated solutions resulted following dissolution, the maximum achievable concentration of each drug, when present in combination, was dramatically lower than when the individual dispersions were dissolved. The maximum achievable solution concentration for systems containing both drugs was found to decrease as the mole fraction of the drug in the amorphous phase decreased. The type of polymer used to formulate the dispersion also appeared to influence the dissolution behavior whereby the HPMCAS dispersions dissolved rapidly, resulting in the generation of a nanodroplets, while the PVP dispersions did not produce as many colloidal species. These results highlight the need to consider potential decreases in achievable supersaturation for formulations containing more than one amorphous compound.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amorphous; Combination products; Dissolution; Solubility

Mesh:

Substances:

Year:  2015        PMID: 26456250     DOI: 10.1016/j.ijpharm.2015.10.026

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

1.  Tailoring supersaturation from amorphous solid dispersions.

Authors:  Na Li; Lynne S Taylor
Journal:  J Control Release       Date:  2018-04-11       Impact factor: 9.776

Review 2.  Recent Advances in Enhancement of Dissolution and Supersaturation of Poorly Water-Soluble Drug in Amorphous Pharmaceutical Solids: A Review.

Authors:  Qin Shi; Fang Li; Stacy Yeh; Sakib M Moinuddin; Junbo Xin; Jia Xu; Hao Chen; Bai Ling
Journal:  AAPS PharmSciTech       Date:  2021-12-10       Impact factor: 3.246

Review 3.  Co-amorphous Drug Delivery Systems: a Review of Physical Stability, In Vitro and In Vivo Performance.

Authors:  Qin Shi; Yanan Wang; Sakib M Moinuddin; Xiaodong Feng; Fakhrul Ahsan
Journal:  AAPS PharmSciTech       Date:  2022-09-19       Impact factor: 4.026

4.  Colloidal aggregation: from screening nuisance to formulation nuance.

Authors:  Ahil N Ganesh; Eric N Donders; Brian K Shoichet; Molly S Shoichet
Journal:  Nano Today       Date:  2018-03-10       Impact factor: 20.722

Review 5.  The Need for Restructuring the Disordered Science of Amorphous Drug Formulations.

Authors:  Khadijah Edueng; Denny Mahlin; Christel A S Bergström
Journal:  Pharm Res       Date:  2017-05-18       Impact factor: 4.200

6.  Impact of Simulated Intestinal Fluids on Dissolution, Solution Chemistry, and Membrane Transport of Amorphous Multidrug Formulations.

Authors:  Mira El Sayed; Amjad Alhalaweh; Christel A S Bergström
Journal:  Mol Pharm       Date:  2021-10-06       Impact factor: 4.939

7.  Amorphous solid dispersion formation via solvent granulation - A case study with ritonavir and lopinavir.

Authors:  Niraj S Trasi; Sonal Bhujbal; Qi Tony Zhou; Lynne S Taylor
Journal:  Int J Pharm X       Date:  2019-11-12

8.  Synthesis and Properties of CurNQ for the Theranostic Application in Ovarian Cancer Intervention.

Authors:  Lara G Freidus; Pradeep Kumar; Thashree Marimuthu; Priyamvada Pradeep; Viness Pillay; Yahya E Choonara
Journal:  Molecules       Date:  2020-09-29       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.